New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 4, 2013
07:34 EDTBIIBBiogen submits application to FDA for factor IX therapy for Hemophilia B
Biogen Idec says it recently submitted a Biologics License Application to the U.S. Food and Drug Administration for the marketing approval of recombinant factor IX Fc fusion protein for the treatment of hemophilia B. rFIXFc is the first product candidate in a new class of long-lasting clotting factor therapies that are being developed with the goals of reducing the burden of treatment for this condition and enhancing protection from bleeding. The regulatory submission was based on results from B-LONG, the largest registrational phase 3 clinical study in hemophilia B to date. Biogen Idec’s BLA submission to the U.S. FDA for rFVIIIFc for use in patients with hemophilia A is on track for filing in 1H 2013.
News For BIIB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent BIIB news | >>
October 24, 2014
16:54 EDTBIIBMarket ends week higher as Apple leads list of earnings winners
Stocks ended the week higher as stronger than expected economic data and upbeat results from a number of companies lifted shares. MACRO NEWS: In the U.S., existing home sales for September and leading economic indicators for the month beat expectations, while weekly jobless claims were roughly in-line with expectations. Markit's “flash” manufacturing Purchasing Managers' Index for October came in at 56.2, versus the consensus forecast for a 57.0 reading... China reported that its GDP rose 7.3% in Q3, above the 7.2% growth expected by economists. HSBC's flash PMI inched up to 50.4 from a final reading of 50.2 in September, beating the consensus forecast for a 50.3 reading. The Asian country said that its industrial production jumped 8% versus the year earlier, easily beating the anticipated 7.5% increase... A euro zone purchasing managers' index increased to 52.2 in October from 52 in September. Most analysts had expected the index to decline modestly. COMPANY NEWS: Apple (AAPL), Microsoft (MSFT), Harley-Davidson (HOG), Yahoo (YHOO), Caterpillar (CAT), diversified manufacturer 3M (MMM) and chip maker Broadcom (BRCM) were among the companies that reported higher than expected profits. Conversely, the bottom lines of IBM (IBM), McDonald's (MCD), Verizon (VZ), AT&T (T), and Angie's List (ANGI) missed expectations... Shares of Amazon (AMZN) fell after the company reported weaker than expected results and provided lower than expected revenue guidance. At least two analysts downgraded the stock following its quarterly report, while a number of others cut their price targets on the shares... Boeing (BA) reported stronger than expected results and raised its full year core EPS guidance, but its stock fell as the airplane maker reduced its full year operating cash flow guidance... Pandora's (P) shares tumbled after the company's Q3 results beat expectations, but its total listener hours declined in Q3 versus Q2... Shares of drug maker Biogen Idec (BIIB) fell after the Q3 sales of its flagship multiple sclerosis treatment, Tecfidera, came in below expectations. Additionally, Biogen reported that one of the patients taking the drug had died after contracting a disease previously linked to MS treatments... BlackBerry (BBRY) rallied following renewed rumors that Chinese computer maker Lenovo (LNVGY) is looking to buy the smartphone maker... At home soda machine maker SodaStream (SODA) rallied after the company said that it would test making some of PepsiCo's (PEP) brands available on its machines. INDEXES: For the week, the Dow gained 2.58% to close at 16,805.41, the S&P 500 rose 4.12% to close at 1,964.58, and the Nasdaq advanced about 5.28% to close at 4,483.71.
09:16 EDTBIIBBiogen weakness creates buying opportunity, says Argus
Subscribe for More Information
October 23, 2014
06:25 EDTBIIBBiogen PML case expected to have minimal impact at Citigroup
Subscribe for More Information
October 22, 2014
16:33 EDTBIIBOn The Fly: Closing Wrap
Subscribe for More Information
13:38 EDTBIIBBiogen price target lowered to $386 from $420 at Piper Jaffray
Subscribe for More Information
12:21 EDTBIIBBiogen upgraded to Outperform from Neutral at RW Baird
Subscribe for More Information
12:09 EDTBIIBOn The Fly: Midday Wrap
Subscribe for More Information
11:38 EDTBIIBBiogen retreats after Tecfidera sales miss, patient death reported
Subscribe for More Information
11:01 EDTBIIBBiogen trading lower on slower growth, PML case, says Deutsche Bank
Deutsche Bank attributes the pullback in shares of Biogen (BIIB) to slower sequential revenue growth and the one PML case with Tecfidera disclosed on today's earnings call. Deutsche believes investors are now favoring Celgene (CELG) over Biogen due to near term headline risks. The firm says it likes Celgene more as well due its pipeline, but keeps a Buy rating on Biogen.
10:46 EDTBIIBBiogen shares defended at Morgan Stanley
Subscribe for More Information
10:42 EDTBIIBBiogen shares defended at Deutsche Bank
Subscribe for More Information
09:46 EDTBIIBBiogen falls, levels to watch
The shares are down sharply following Q3 results and a guidance boost for FY14, At the current price of $294.96, shares are lower by 9.8%. Support is at the session low at $290.94. Resistance is at $299.71.
09:21 EDTBIIBOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Dow Chemical (DOW), up 3.7%... iRobot (IRBT), up 12%... Six Flags (SIX), up 13%... GlaxoSmithKline (GSK), up 2%... Broadcom (BRCM), up 7%... Boston Scientific (BSX), up 4.3%... Abbott (ABT), up 1.8%... Yahoo! (YHOO), up 6%. ALSO HIGHER: Blue Earth (BBLU), up 26.4% after CEO says statements in Seeking Alpha blog are "false and misleading."... GW Pharmaceuticals (GWPH), up 5.4% after Epidiolex receives orphan designation from EMA. DOWN AFTER EARNINGS: 3D Systems (DDD), down 15%... Biogen (BIIB), down 7%... Lumber Liquidators (LL), down 13.4%... Norfolk Southern (NSC), down 3%... Angie's List (ANGI), down 8.8%. ALSO LOWER: Nanosphere (NSPH), down 33% after filing secondary, reporting preliminary Q3 revenue... Himax Technologies (HIMX), down 16% after announcing that Google (GOOG) will not exercise an additional investment option in the company... Cree (CREE), down 10.5%, downgraded at DA Davidson and Canaccord following the company's Q1 earnings results... Ocwen Financial (OCN), down 7% after downgraded to Hold at Evercore, downgraded to Neutral at BofA Merrill Lynch... VMware (VMW), down 7.8%, downgraded at Nomura and Raymond James following the company's Q3 results.
09:12 EDTBIIBBiogen down 6% after Q3 report, disclosure of patient death
Subscribe for More Information
07:08 EDTBIIBBiogen reports Q3 TECFIDERA revenues $787M
Subscribe for More Information
07:03 EDTBIIBBiogen raises FY14 adjusted EPS view to $13.45-$13.55, consensus $13.10
Still sees revenue growth 38%-41% vs. 2013, consensus $9.69B. $&D expense is expected to be approximately 20% to 21% of total revenue.
07:02 EDTBIIBBiogen reports Q3 adjusted EPS $3.80, consensus $3.46
Reports Q3 revenue $2.51B, consensus $2.48B.
October 21, 2014
15:35 EDTBIIBNotable companies reporting before tomorrow's open
Subscribe for More Information
06:54 EDTBIIBBiogen October weekly volatility elevated into Q3 and outlook
Subscribe for More Information
October 20, 2014
07:32 EDTBIIBCubist names Perez CEO to succeed Bonney
Subscribe for More Information
1 | 2 | all recent BIIB news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use